
[ Tue, Jan 21st ]: electrive
[ Tue, Jan 21st ]: NextBigFuture
[ Tue, Jan 21st ]: Gizmodo
[ Tue, Jan 21st ]: Gizmodo
[ Tue, Jan 21st ]: Graphic
[ Tue, Jan 21st ]: TechRadar
[ Tue, Jan 21st ]: STAT
[ Tue, Jan 21st ]: CIO
[ Tue, Jan 21st ]: businessday
[ Tue, Jan 21st ]: MSN
[ Tue, Jan 21st ]: MSN
[ Tue, Jan 21st ]: MSN
[ Tue, Jan 21st ]: TechRadar
[ Tue, Jan 21st ]: NDTV
[ Tue, Jan 21st ]: ProPakistani
[ Tue, Jan 21st ]: MSN

[ Mon, Jan 20th ]: Reuters
[ Mon, Jan 20th ]: Techopedia
[ Mon, Jan 20th ]: Oneindia
[ Mon, Jan 20th ]: Forbes
[ Mon, Jan 20th ]: WOFL
[ Mon, Jan 20th ]: TechCrunch
[ Mon, Jan 20th ]: SlashGear
[ Mon, Jan 20th ]: NextBigFuture
[ Mon, Jan 20th ]: SHINE
[ Mon, Jan 20th ]: MSN
[ Mon, Jan 20th ]: MSN
[ Mon, Jan 20th ]: WRVO
[ Mon, Jan 20th ]: cybernews
[ Mon, Jan 20th ]: MSN
[ Mon, Jan 20th ]: SpaceNews
[ Mon, Jan 20th ]: Reuters
[ Mon, Jan 20th ]: MSN
[ Mon, Jan 20th ]: Tuko
[ Mon, Jan 20th ]: Forbes
[ Mon, Jan 20th ]: news10nbc

[ Sun, Jan 19th ]: NHK
[ Sun, Jan 19th ]: Forbes
[ Sun, Jan 19th ]: Yahoo
[ Sun, Jan 19th ]: BGR
[ Sun, Jan 19th ]: BBC
[ Sun, Jan 19th ]: MLive
[ Sun, Jan 19th ]: nation
[ Sun, Jan 19th ]: MSN
[ Sun, Jan 19th ]: Time
[ Sun, Jan 19th ]: MSN
[ Sun, Jan 19th ]: MSN
AstraZeneca secures first BTK approval in first-line mantle cell lymphoma


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biochemistry/astrazeneca-secures-first-btk-approval-in-first-line-mantle-cell-lymphoma/ar-AA1xxTxt ]